Fig. 4

Schematic diagram of identification and validation of lncRNAs. A, RNA sequencing analyses in discovery cohort identified list of lncRNAs overexpressed in T-ALL. B, Validation of lncRNAs by qRT-PCR in T-ALL and identification of differential expressed lncRNAs in T-ALL vs. B-ALL. C, Clinical correlation and survival analysis identified RP11-620J15.3 as predictor of better survival while CRNDE, RP11-472G21.2 and LINC00977 were identified as differentially expressed in T-ALL.